These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2766722)

  • 21. A double-blind, placebo-controlled evaluation of the effect of oral doses of rizatriptan 10 mg on oral contraceptive pharmacokinetics in healthy female volunteers.
    Shadle CR; Liu G; Goldberg MR
    J Clin Pharmacol; 2000 Mar; 40(3):309-15. PubMed ID: 10709161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic interaction between ethinyl estradiol, norethindrone and darunavir with low-dose ritonavir in healthy women.
    Sekar VJ; Lefebvre E; Guzman SS; Felicione E; De Pauw M; Vangeneugden T; Hoetelmans RM
    Antivir Ther; 2008; 13(4):563-9. PubMed ID: 18672535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic interaction between bosentan and the oral contraceptives norethisterone and ethinyl estradiol.
    van Giersbergen PL; Halabi A; Dingemanse J
    Int J Clin Pharmacol Ther; 2006 Mar; 44(3):113-8. PubMed ID: 16550733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetic interaction between an oral contraceptive containing ethinyl estradiol and norethindrone and the HCV protease inhibitor telaprevir.
    Garg V; van Heeswijk R; Yang Y; Kauffman R; Smith F; Adda N
    J Clin Pharmacol; 2012 Oct; 52(10):1574-83. PubMed ID: 22039291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of vicriviroc with or without ritonavir on oral contraceptive pharmacokinetics: a randomized, open-label, parallel-group, fixed-sequence crossover trial in healthy women.
    Kasserra C; Li J; March B; O'Mara E
    Clin Ther; 2011 Oct; 33(10):1503-14. PubMed ID: 22015327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of ethinyl estradiol and mestranol.
    Goldzieher JW; Brody SA
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2114-9. PubMed ID: 2256522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.
    Scheffler MR; Colburn W; Kook KA; Thomas SD
    Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioimmunoassay of unconjugated plasma ethynylestradiol in women given a single oral dose of ethynylestradiol or mestranol.
    de la Pena A; Chenault CB; Goldzieher JW
    Steroids; 1975 Jun; 25(6):773-80. PubMed ID: 1154455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissolution testing of norethindrone:ethinyl estradiol, norethindrone:mestranol, and norethindrone acetate:ethinyl estradiol combination tablets.
    Nguyen HT; Shiu GK; Worsley WN; Skelly JP
    J Pharm Sci; 1990 Feb; 79(2):163-7. PubMed ID: 2324966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationale for a new triphasic oral contraceptive.
    Pasquale SA
    Int J Fertil; 1986; 31 SU [UPDATE]():13-9. PubMed ID: 2899554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
    Wild RA; Demers LM; Applebaum-Bowden D; Lenker R
    Contraception; 1991 Aug; 44(2):113-24. PubMed ID: 1893706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of troglitazone on the pharmacokinetics of an oral contraceptive agent.
    Loi CM; Stern R; Koup JR; Vassos AB; Knowlton P; Sedman AJ
    J Clin Pharmacol; 1999 Apr; 39(4):410-7. PubMed ID: 10197300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of norethisterone from two different combination contraceptive pills in Indian women.
    Sivakumar B; Prasad KV; Ravinder P; Ramalakshmi BA; Narasinga Rao BS
    Indian J Physiol Pharmacol; 1989; 33(1):10-4. PubMed ID: 2737742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromatographic patterns of urinary ethynyl estrogen metabolites in various populations.
    Williams MC; Goldzieher JW
    Steroids; 1980 Sep; 36(3):255-82. PubMed ID: 7434400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroid contraceptives in non-human primates (II). Metabolic fate of synthetic estrogens in the baboon after exposure to oral contraceptives.
    Kulkarni BD; Avila TD; O'Leary JA
    Contraception; 1977 Mar; 15(3):307-17. PubMed ID: 880810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives.
    Fels H; Steward R; Melamed A; Granat A; Stanczyk FZ; Mishell DR
    Contraception; 2013 Jun; 87(6):732-7. PubMed ID: 23352800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.